BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF THE PAR-2 SIGNALING PATHWAY
                        
                            
                                申请人:VERTEX PHARMACEUTICALS INCORPORATED
                            
                            
                                公开号:US20180057505A1
                            
                            
                                公开(公告)日:2018-03-01
                            
                            The compounds of formula I, wherein the variables are as defined herein, and pharmaceutically acceptable salts thereof are useful as inhibitors of the PAR-2 signaling pathway. The compounds of formula I and pharmaceutically acceptable compositions comprising such compounds can be employed for treating various diseases, disorders, and conditions.